These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 29332563)
1. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update. de Freitas Silva M; Dias KST; Gontijo VS; Ortiz CJC; Viegas C Curr Med Chem; 2018; 25(29):3491-3525. PubMed ID: 29332563 [TBL] [Abstract][Full Text] [Related]
2. Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases. Gontijo VS; Viegas FPD; Ortiz CJC; de Freitas Silva M; Damasio CM; Rosa MC; Campos TG; Couto DS; Tranches Dias KS; Viegas C Curr Neuropharmacol; 2020; 18(5):348-407. PubMed ID: 31631821 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core. Lin H; Li Q; Gu K; Zhu J; Jiang X; Chen Y; Sun H Curr Top Med Chem; 2017; 17(27):3000-3016. PubMed ID: 28714419 [TBL] [Abstract][Full Text] [Related]
4. The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease. Mesiti F; Chavarria D; Gaspar A; Alcaro S; Borges F Eur J Med Chem; 2019 Nov; 181():111572. PubMed ID: 31404859 [TBL] [Abstract][Full Text] [Related]
5. Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents. George N; Jawaid Akhtar M; Al Balushi KA; Alam Khan S Bioorg Chem; 2022 Oct; 127():105941. PubMed ID: 35714473 [TBL] [Abstract][Full Text] [Related]
6. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design. Kumar A; Tiwari A; Sharma A Curr Neuropharmacol; 2018; 16(6):726-739. PubMed ID: 29542413 [TBL] [Abstract][Full Text] [Related]
7. CADD Modeling of Multi-Target Drugs Against Alzheimer's Disease. Ambure P; Roy K Curr Drug Targets; 2017; 18(5):522-533. PubMed ID: 26343117 [TBL] [Abstract][Full Text] [Related]
8. [Multifunctional ligands--a new approach in the search for drugs against multi-factorial diseases]. Wichur T; Malawska B Postepy Hig Med Dosw (Online); 2015 Jan; 69():1423-34. PubMed ID: 27259214 [TBL] [Abstract][Full Text] [Related]
9. Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018). Mishra P; Kumar A; Panda G Bioorg Med Chem; 2019 Mar; 27(6):895-930. PubMed ID: 30744931 [TBL] [Abstract][Full Text] [Related]
10. Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer's Disease. Dias KS; Viegas C Curr Neuropharmacol; 2014 May; 12(3):239-55. PubMed ID: 24851088 [TBL] [Abstract][Full Text] [Related]
11. Novel Multitarget Hybrid Compounds for the Treatment of Alzheimer's Disease. Michalska P; Buendia I; Del Barrio L; Leon R Curr Top Med Chem; 2017; 17(9):1027-1043. PubMed ID: 27697052 [TBL] [Abstract][Full Text] [Related]
12. Multi-targeting Strategies for Alzheimer's Disease Therapeutics: Pros and Cons. Das S; Basu S Curr Top Med Chem; 2017; 17(27):3017-3061. PubMed ID: 28685694 [TBL] [Abstract][Full Text] [Related]
13. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease. Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079 [TBL] [Abstract][Full Text] [Related]
14. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease. Wu WY; Dai YC; Li NG; Dong ZX; Gu T; Shi ZH; Xue X; Tang YP; Duan JA J Enzyme Inhib Med Chem; 2017 Dec; 32(1):572-587. PubMed ID: 28133981 [TBL] [Abstract][Full Text] [Related]
15. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment. Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870 [TBL] [Abstract][Full Text] [Related]
16. Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach. Kumar S; Mahajan A; Ambatwar R; Khatik GL Curr Med Chem; 2024; 31(37):6032-6062. PubMed ID: 37861025 [TBL] [Abstract][Full Text] [Related]
17. Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer's Disease Therapy: Advances in Chemical and Biological Research. Jankowska A; Wesolowska A; Pawlowski M; Chlon-Rzepa G Curr Med Chem; 2018; 25(17):2045-2067. PubMed ID: 28554324 [TBL] [Abstract][Full Text] [Related]
18. Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease. Spilovska K; Korabecny J; Nepovimova E; Dolezal R; Mezeiova E; Soukup O; Kuca K Curr Top Med Chem; 2017; 17(9):1006-1026. PubMed ID: 27697055 [TBL] [Abstract][Full Text] [Related]
19. Multi-target-directed ligands in Alzheimer's disease treatment. Bajda M; Guzior N; Ignasik M; Malawska B Curr Med Chem; 2011; 18(32):4949-75. PubMed ID: 22050745 [TBL] [Abstract][Full Text] [Related]
20. Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease. Wang T; Liu XH; Guan J; Ge S; Wu MB; Lin JP; Yang LR Eur J Med Chem; 2019 May; 169():200-223. PubMed ID: 30884327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]